Sarepta Therapeutics enters into ATM equity offering sales agreement with Further Lane Securities
Sales proceeds from the offering will be used by Sarepta for general corporate purposes, such as manufacturing scale up for eteplirsen. Additionally, it also intends to use the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.